These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3104732)

  • 21. To the editor: effect of anesthetic gases on the growth of Pseudomonas aeruginosa, Haemophilus influenzae, and Staphylococcus aureus.
    A-Rahman A; Pedler S; Bray R; O'Brien CJ
    Pediatr Pulmonol; 2002 Sep; 34(3):226-7. PubMed ID: 12203853
    [No Abstract]   [Full Text] [Related]  

  • 22. Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus.
    Birla SS; Tiwari VV; Gade AK; Ingle AP; Yadav AP; Rai MK
    Lett Appl Microbiol; 2009 Feb; 48(2):173-9. PubMed ID: 19141039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of irgasan on bacterial growth and its adsorption into the cell wall.
    Meincke BE; Kranz RG; Lynch DL
    Microbios; 1980; 28(113-114):133-47. PubMed ID: 6787394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC; Foster-Frey J; Donovan DM
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protease-deficient mutants of Pseudomonas aeruginosa: pleiotropic changes in activity of other extracellular enzymes.
    Wretlind B; Sjöberg L; Wadström T
    J Gen Microbiol; 1977 Dec; 103(2):329-36. PubMed ID: 413877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus.
    O'Flaherty S; Coffey A; Meaney W; Fitzgerald GF; Ross RP
    J Bacteriol; 2005 Oct; 187(20):7161-4. PubMed ID: 16199588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secreted LasA of Pseudomonas aeruginosa is a staphylolytic protease.
    Kessler E; Safrin M; Olson JC; Ohman DE
    J Biol Chem; 1993 Apr; 268(10):7503-8. PubMed ID: 8463280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of effects of penicillin minimal inhibitory and sub-inhibitory concentration on Staphylococcus aureus and Streptococcus faecium does not support the view that antibiotic sub-inhibitory concentrations can specifically interfere with bacterial virulence.
    Satta G; Rossi L; Bertoloni G; Cornaglia G; Canepari P; Fontana R
    Microbiologica; 1986 Jul; 9(3):305-19. PubMed ID: 3747854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lytic action of lysoamidase from Xanthomonas sp. correlates with the presence of the target ribitol teichoic acids in the cell wall of gram-positive bacteria].
    Kulaev IS; Naumova IB; Streshinskaia GM; Tul'skaia EM; Stepnaia OA; Severin AI; Begunova EA
    Mikrobiologiia; 1996; 65(3):326-32. PubMed ID: 8992241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phage release from biofilm and planktonic Staphylococcus aureus cells.
    Resch A; Fehrenbacher B; Eisele K; Schaller M; Götz F
    FEMS Microbiol Lett; 2005 Nov; 252(1):89-96. PubMed ID: 16213676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antibacterial activity of topical anesthetics.
    Mullin GS; Rubinfeld RS
    Cornea; 1997 Nov; 16(6):662-5. PubMed ID: 9395876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electron microscope study of the effect of sanguiritrin on bacteria in vitro].
    Bykov AS; Vichkanova SA; Seleznev AS; Fateeva TV; Pashkov EP
    Antibiotiki; 1983 Jun; 28(6):421-4. PubMed ID: 6410986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of salt concentration and growth phase on MRSA solar and germicidal ultraviolet radiation resistance.
    Sheldon JL; Kokjohn TA; Martin EL
    Ostomy Wound Manage; 2005 Jan; 51(1):36-8, 42-4, 46 passim. PubMed ID: 15695834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Isolation of Staphylococcus aureus protoplasts using lysoamidase].
    Petrov VV; Ratner EN; Severin AI; Fikhte BA; Kulaev IS
    Prikl Biokhim Mikrobiol; 1990; 26(3):413-21. PubMed ID: 2202987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of mesosomes of Staphylococcus aureus during autolysis.
    Hirai Y
    Acta Med Okayama; 1979 Aug; 33(4):219-38. PubMed ID: 91308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of lytic enzymes on Staphylococcus and the possibilities of their combined use with antibiotics].
    Babenko IuS; Gnilomedova LE; Kukushkina NV
    Antibiot Khimioter; 1988 Feb; 33(2):115-20. PubMed ID: 3288149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STAPHYLOLYTIC SUBSTANCE FROM A SPECIES OF PSEUDOMONAS.
    ZYSKIND JW; PATTEE PA; LACHE M
    Science; 1965 Mar; 147(3664):1458-9. PubMed ID: 14263759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A protease with staphylolytic activity from Pseudomonas aeruginosa PAKS I.
    Carnicero A; Falcón MA; Mansito TB; Roldán JM
    FEMS Microbiol Lett; 1990 Jul; 58(2):171-5. PubMed ID: 2121586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Action of rifampicin on the ultrastructure of Staphylococcus cells].
    Zhukov VG; Navashin SM; Zaslavaskaia PL
    Antibiotiki; 1977; 22(2):143-5. PubMed ID: 871212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of bacteriolytic preparation lysoamidase on Staphylococcus aureus 209P cells].
    Abramochkin GV; Ratner EN; Petrov VV; Severin AI; Suzina NE; Fikhte BA; Kulaev IS
    Prikl Biokhim Mikrobiol; 1990; 26(1):93-100. PubMed ID: 2190209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.